Diabetes costs New York State an estimated $12.9 billion annually.
Value of Ambulatory Care Measures: A Review of Clinical and Financial Impact from an Employer/Payer Perspective
Data
06/05/2008
Paper examines 62 ambulatory care measures selected for a pay-for-performance initiative at a specialty organization and shows which measures are and are not clinically effective and cost-effective.
Full resource here.
